Ep lab digest features physician experience with biosig's cardiac signal acquisition technology

Westport, ct, april 08, 2021 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) ("biosig" or the "company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ecg and intra-cardiac signals, today announced the pure ep™ system was highlighted in a feature interview for the april issue of ep lab digest, a leading industry publication for electrophysiology professionals.
BSGM Ratings Summary
BSGM Quant Ranking